Related references
Note: Only part of the references are listed.Can Botulinum Toxin A Play a Role in Treatment of Chronic Pelvic Pain Syndrome in Female Patients?-Clinical and Animal Evidence
Chin-Li Chen et al.
TOXINS (2020)
Meta-Analysis of Randomized Controlled Trials Using Botulinum Toxin A at Different Dosages for Urinary Incontinence in Patients With Overactive Bladder
Qin-Qin Gong et al.
FRONTIERS IN PHARMACOLOGY (2020)
Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis
Jing-Liang Chen et al.
INVESTIGATIVE AND CLINICAL UROLOGY (2020)
Botulinum Toxin Type A and Physiotherapy in Spasticity of the Lower Limbs Due to Amyotrophic Lateral Sclerosis
Riccardo Marvulli et al.
TOXINS (2019)
Defining spasticity: a new approach considering current movement disorders terminology and botulinum toxin therapy
Dirk Dressler et al.
JOURNAL OF NEUROLOGY (2018)
Antipruritic Effects of Botulinum Neurotoxins
Parisa Gazerani
TOXINS (2018)
Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology
Marco Pirazzini et al.
PHARMACOLOGICAL REVIEWS (2017)
Therapeutic Plasma Exchange in a rare case myasthenic crisis after Botox injection
Azita Chegini
ATHEROSCLEROSIS SUPPLEMENTS (2017)
Botulinum toxin drugs: brief history and outlook
D. Dressler
JOURNAL OF NEURAL TRANSMISSION (2016)
Myasthenia gravis - autoantibody characteristics and their implications for therapy
Nils Erik Gilhus et al.
NATURE REVIEWS NEUROLOGY (2016)
Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache Report of the Guideline Development Subcommittee of the American Academy of Neurology
David M. Simpson et al.
NEUROLOGY (2016)
International consensus guidance for management of myasthenia gravis: Executive summary
Donald B. Sanders et al.
NEUROLOGY (2016)
Myasthenia Gravis after Botulinum Toxin Type A Injection
Hacer Durmus Tekce et al.
TURKISH JOURNAL OF NEUROLOGY (2016)
Myasthenia gravis exacerbation with low dose ocular botulinum toxin for epiphoria
Jennifer Watts et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2015)
Safety of Botulinum Toxin A in Aesthetic Treatments: A Systematic Review of Clinical Studies
Maurizio Cavallini et al.
DERMATOLOGIC SURGERY (2014)
Botulinum neurotoxins: genetic, structural and mechanistic insights
Ornella Rossetto et al.
NATURE REVIEWS MICROBIOLOGY (2014)
Subclinical Myasthenia Gravis causing increased sensitivity to botulinum toxin therapy
Dirk Dressler
JOURNAL OF NEURAL TRANSMISSION (2010)
Botulinum toxin treatment for blepharospasm associated with myasthenia gravis
Kenju Hara et al.
MOVEMENT DISORDERS (2007)
Botulinum toxin type A therapy in a patient with cervical dystonia and amyotrophic lateral sclerosis
Carlos Singer et al.
MOVEMENT DISORDERS (2007)
Systemic effect of local and small-dose botulinum toxin injection to unmask subclinical myasthenia gravis
T Iwase et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2006)
Treatment with botulinum toxin in a patient with myasthenia gravis and cervical dystonia
A Fasano et al.
NEUROLOGY (2005)
Share Paper
